Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Seattle Genetics Inc.
Woman and Man
Between 12 years
and 99 years
Seattle Genetics Inc.
Update Il y a 4 ans
Seattle Genetics SG035-0004 : Essai de phase 2 évaluant l’efficacité et la tolérance du SNG-35 (anticorps anti-CD30), chez des patients ayant un lymphome à grandes cellules anaplasiques. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A phase 2 study of SGN-35 in treatment of patients with relapsed or refractory systemic anaplastic large cell lymphoma (ALCL),
Country
France
organs
Lymphomes non hodgkinien
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Previous
1
2